A study has underlined the potential safety and efficacy benefits offered by golimumab, a drug treatment for psoriatic arthritis. Led by scientists at the University of California, the clinical trial aimed to assess the effectiveness of the drug over a period of five years, with a total of 405 patients being involved in the research. Visit bit.ly/1jvG4M0 for more information about their findings.
Posted on: Tue, 22 Apr 2014 16:17:08 +0000
Trending Topics
Recently Viewed Topics
© 2015